NOCIMED, INC. AMENDMENT NO. 3 TO SERIES B-1 PREFERRED STOCK PURCHASE AGREEMENTSeries B-1 Preferred Stock Purchase Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software • Delaware
This Amendment No. 3 to Series B-1 Preferred Stock Purchase Agreement (the "Amendment") is made as of April 24, 2018 (the "Amendment Effective Date") by and between Nocimed, Inc., a Delaware corporation (the "Company"), and the purchaser set forth on the signature page hereto (the "Purchaser").
FIRST AMENDMENT TO MARKETING AGREEMENTMarketing Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software
This FIRST AMENDMENT TO MARKETING AGREEMENT (the “Amendment”) is dated and effective as of July 27, 2017 (the “Amendment Date”), by and between NOCIMED, INC. a Delaware corporation with its principal place of business at 370 Convention Way, Redwood City, CA 94063 (“Nocimed”), and NUVASIVE, INC., a Delaware corporation with its principal place of business at 7475 Lusk Boulevard, San Diego, CA 92121 (“NuVasive”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Marketing Agreement (as defined below).
NOCIMED, INC. AMENDMENT NO. 1 TO SERIES B-1 PREFERRED STOCK PURCHASE AGREEMENTSeries B-1 Preferred Stock Purchase Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software • Delaware
This Amendment No. 1 to Series B-1 Preferred Stock Purchase Agreement (the “Amendment”) is made as of February 1, 2018 (the “Amendment Effective Date”) by and between Nocimed, Inc., a Delaware corporation (the “Company”), and the purchaser set forth on the signature page hereto (the “Purchaser”).
FIRST AMENDMENT TO RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTRight of First Refusal and Co-Sale Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software
This FIRST AMENDMENT TO AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (the “Amendment”) is dated and effective as of February 28, 2020 (the “Amendment Date”), by and among NOCIMED, INC., a Delaware corporation (the “Company”), and the parties set forth on the signature pages hereto. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Co-Sale Agreement (as defined below).
SERIES B PREFERRED STOCK PURCHASE AGREEMENTSeries B Preferred Stock Purchase Agreement • October 25th, 2021 • Nocimed, Inc. • Services-prepackaged software • Delaware
THIS SERIES B PREFERRED STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of February 18, 2015, by and among NOCIMED, INC., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, whose names are set forth on the Schedule of Purchasers attached hereto as Schedule A (which persons and entities are hereinafter collectively referred to as “Purchasers” and each individually as a “Purchaser”).
